Regeneron Pharmaceuticals, Inc. - Common Stock - fluxo de caixa (NASDAQ:REGN)

Financials

Visão geral Relatórios Estatísticas Dividendos

Fluxo de caixa operacional 2.62 B7.08 B5.01 B4.59 B4.42 B4.98 B 5.01 B Fluxo de caixa de investimento -70.6 M-5.38 B-3.78 B-3.19 B-2.47 B-629.1 M -1.71 B Fluxo de caixa de financiamento -1.97 B-1.01 B-1.01 B-1.79 B-2.2 B-3.72 B -3.43 B Fluxo de caixa livre 2 B6.53 B4.42 B3.88 B3.66 B4.08 B 4.11 B

Regeneron Pharmaceuticals, Inc. - Common Stock

Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap.

REGN

Financials

Regeneron Pharmaceuticals, Inc. - Common Stock

Notícias

Regeneron (REGN) Down 12.1% Since Last Earnings Report: Can It Rebound?

OMS identifica tratamentos e vacinas contra o Ebola para teste em ensaios clínicos em meio a surto

Why Apogee Slipped On Its Dupixent-Rivaling Eczema Results

Are Wall Street Analysts Predicting Regeneron Pharmaceuticals Stock Will Climb or Sink?

Here's Why Regeneron (REGN) is a Strong Value Stock

EMA aceita terapia gênica da Regeneron para perda auditiva rara

These Are The Upcoming Catalysts For Crispr Therapeutics Stock (NASDAQ:CRSP)

Regeneron divulga resultados positivos de ensaio para tratamento de amiloidose

BAYRY's Kerendia Label Expansion Application Gets Priority Review

Apogee Therapeutics: Targeting Atopic Dermatitis (NASDAQ:APGE)

Regeneron & Parabilis Sign Oncology Collaboration Worth Up to $2.2B

Can Intellia's Pipeline Push Drive Long-Term Growth Amid Rivalry?